RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > The Status of Consumer Drug Advertising in Canada

The Status of Consumer Drug Advertising in Canada

Posted 01 May 2008

Direct-to-Consumer Advertising (DTCA) has become an accepted reality in the US, where at least three types are regularly used to promote prescription drugs.

"Branded" advertisements promote the drug and its therapeutic effects. "Unbranded" advertisements, a.k.a. "talk to your doctor" advertisements, are used to educate consumers about treatment options that may be available, although the drug remains unnamed. Reminder advertisements simply feature the name of the drug, with no mention of therapeutic claims, diseases or conditions.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.